Reuters · Kane Wu ·

Shanghai-based Anew Labs, a ByteDance spinoff using AI for drug discovery, raised $290M from HSG, IDG Capital, and others at a $1.5B valuation

Chinese social media and internet company ByteDance has completed a $290 million fundraising for its AI drugmaking unit after spinning …

TikTok AI Venture Capital

In this story Anew Labs ByteDance HSG IDG Capital

Lead Source

Reuters — Shanghai-based Anew Labs, a ByteDance spinoff using AI for drug discovery, raised $290M from HSG, IDG Capital, and others at a $1.5B valuation ↗

How this story grew

Coverage · 0 Discussion · 0

Sep 16Sep 17

More

pharmaphorum: pharmaphorum

Related stories

The Information: Beijing-based Naive AI, which plans to release its first LLM as early as September, is now valued at $1.4B+ after raising $400M across three rounds

Financial Times: AI video generation startup Higgsfield raised $400M from DST, Goldman Sachs, Liberty Global, Intel, and others at a $5.4B valuation, up from $1.3B in January

Bloomberg: Gimlet Labs, which helps customers divide AI tasks across multiple chip types, raised $300M led by a16z at a $3B valuation, six months after an $80M Series A

Reuters: Chinese EV maker XPeng says its robotics business raised $900M+ led by IDG and Gaorong Ventures at a $6.3B valuation, with Tencent and Alibaba participating

Bloomberg: Alibaba is set to lead a $300M round in AI model testing startup UniPat AI at a $2.5B valuation; UniPat founder Li Kuan worked at Alibaba's Tongyi Lab

Discuss with AI

ChatGPT ↗ Claude ↗

← Back to TechSnif